Metraipolis › archive › dc_ee7c2587fa04
A meta-analysis on the effectiveness and safety of FOLFOX plus bevacizumab for colorectal cancer treatment — Europe PMC PMID:42255214
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42255214
- DOI
- 10.3389/fonc.2026.1834867
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:19:54.097Z
- SHA-256 of the archived text
a71a17fe9184b575d6cfbe5f3d068dd98a8fdc5c733b563b941d464f2736b00e- Stable URL of this page
https://metraipolis.com/documento/dc_ee7c2587fa04
How to cite
A meta-analysis on the effectiveness and safety of FOLFOX plus bevacizumab for colorectal cancer treatment — Europe PMC PMID:42255214 — Europe PMC (en), https://europepmc.org/article/MED/42255214 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee7c2587fa04 (Metraipolis archive dc_ee7c2587fa04, sha256 a71a17fe9184b575d6cfbe5f3d068dd98a8fdc5c733b563b941d464f2736b00e)
BibTeX
@misc{dcee7c2587fa04,
title = {A meta-analysis on the effectiveness and safety of FOLFOX plus bevacizumab for colorectal cancer treatment — Europe PMC PMID:42255214},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42255214},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee7c2587fa04; sha256 a71a17fe9184b575d6cfbe5f3d068dd98a8fdc5c733b563b941d464f2736b00e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42255214. Agents can read the archived copy with the MCP tool read_document.